Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.
about
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseRapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicityPerispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanismEmerging Link between Alzheimer's Disease and Homeostatic Synaptic PlasticityTNF-α/NF-κB signaling in the CNS: possible connection to EPHB2Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.Tumor necrosis factor α Inhibition for Alzheimer's Disease.Systemic inflammation and disease progression in Alzheimer disease.Reduced lean mass in early Alzheimer disease and its association with brain atrophy.Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology.Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.Design and synthesis of neuroprotective methylthiazoles and modification as NO-chimeras for neurodegenerative therapy.Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease.Tumor necrosis factor-alpha (TNF-α) levels in aqueous humor of primary open angle glaucomaNovel analogues of chlormethiazole are neuroprotective in four cellular models of neurodegeneration by a mechanism with variable dependence on GABA(A) receptor potentiation.Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus.Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.Depression, strokes and dementia: new biological insights into an unfortunate pathway.Genetic deletion of TNF receptor suppresses excitatory synaptic transmission via reducing AMPA receptor synaptic localization in cortical neurons.Population Difference in the Associations of KLOTH Promoter Methylation with Mild Cognitive Impairment in Xinjiang Uygur and Han Populations.TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseasesMeta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease.Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's diseaseThe association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing StudyThe microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor.The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.Predicting delirium duration in elderly hip-surgery patients: does early symptom profile matter?Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators.Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammationConstruction of AAV-rat-IL4 and Evaluation of its Modulating Effect on Aβ (1-42)-Induced Proinflammatory Cytokines in Primary Microglia and the B92 Cell Line by Quantitative PCR AssayTargeting insulin-like growth factor-1 to treat Alzheimer's disease.Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's diseaseEffects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trialDepression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease.Biomarkers related to aging in human populations.
P2860
Q21093232-C2BE92FE-047D-40CC-AD4C-B1DE76AD26C1Q21261380-2BE42B23-62E3-4D91-A5B9-49A0217102B9Q21284512-1DF57867-BC16-4D32-AB53-DF568A6CEFB6Q24652684-F167FCAA-7C82-46DA-8DF0-55B2C20A259FQ26750576-9343AE5B-C0DB-4165-89C3-3F8B9006081DQ26828831-615524F0-839E-4A03-A296-8D29B657E56EQ27010652-F1966FF8-F0F6-4CDD-94A8-85DAC4FD67CFQ30481096-46158817-D853-4E88-9DC0-FBB235D2C412Q33704278-FA1C40B5-36C8-4CC4-9089-8DB31191DA0BQ33765718-E2BA3923-276F-46CA-90A9-DE6B79256150Q33791606-841613DB-C561-44D2-A6DF-DA96FF6C176CQ34169743-C0C4B541-38EC-49A4-9CEC-9DE514BFD35FQ34200691-632114AB-3330-4544-A0B2-852C1B2060F4Q34277859-EC0C01F2-6E44-4566-B370-B0C8F4AECEF5Q34332249-BDD748CF-FD85-4C99-BCC1-F9EF6E34B849Q34584102-D4BC6781-A235-4E3F-8119-748907CCD61EQ34987608-7CD9BA75-CE5D-48F4-B1BF-F730EE624272Q35015325-528649C6-EE5A-44F6-9C51-5FAB963923B7Q35063700-DB24BD10-6E63-46AE-AF9B-3419119BAE17Q35530481-313A5F32-49CF-40F0-B28A-23C98ECCE895Q35636066-87C0CC9C-B917-49DF-9410-27D7F81FFE27Q35647999-C67E5567-9AD4-43FF-8E7F-7DCEC78B8DF4Q35703387-38165554-3D7E-4954-92FC-0F473FABCB55Q35818467-604964AA-BC2C-4E4E-89E7-EFFE31C0B3ACQ36023238-D185BF19-8689-46F8-9E20-D75531D3C58EQ36030348-4D5BF8EC-0992-4053-BDC2-A71942AD54DDQ36112435-2CA55E1E-19BD-4806-B2B2-724F1928A9EDQ36253078-3C6B2C15-85CF-4560-85BD-425EEDBB1C80Q36369776-AF959D05-DD25-4090-BD5B-BBB37E1C2C81Q36686413-7CB5AB7A-000A-488B-8889-F8D2325E2749Q36692075-910477FE-EEB7-4677-A406-8B6860AEDBF0Q36715802-DE1E5D25-57A8-416B-AD5A-3C3B22E64DE2Q36813784-67A7DFEA-369A-422E-A61B-3A3EC79D95CBQ36910522-AC946B2D-E0AE-4D42-B182-E78D9073ACC1Q37004725-4B765986-BF7D-49EF-AEE5-7DDB9862131AQ37062425-063071FA-3638-4FF3-8282-0D38B150929FQ37151258-C1BED2A3-002D-4863-BA2D-C2BB4D23C04DQ37183514-A9F9BF7B-B118-4A5A-B67D-B0FA28728A4EQ37288410-D5CFEBA7-7D4F-49F6-8776-ECADEE7A25A1Q37323794-AC69D7C9-4830-4B69-B7AB-5665B1F21EE7
P2860
Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Serum TNF-alpha levels are inc ...... ee IGF-I in Alzheimer disease.
@en
Serum TNF-alpha levels are inc ...... ee IGF-I in Alzheimer disease.
@nl
type
label
Serum TNF-alpha levels are inc ...... ee IGF-I in Alzheimer disease.
@en
Serum TNF-alpha levels are inc ...... ee IGF-I in Alzheimer disease.
@nl
prefLabel
Serum TNF-alpha levels are inc ...... ee IGF-I in Alzheimer disease.
@en
Serum TNF-alpha levels are inc ...... ee IGF-I in Alzheimer disease.
@nl
P2093
P1476
Serum TNF-alpha levels are inc ...... ee IGF-I in Alzheimer disease.
@en
P2093
Antón Alvarez
Carolina Sanpedro
Manuel Aleixandre
Manuel García-Fantini
P304
P356
10.1016/J.NEUROBIOLAGING.2006.02.012
P577
2006-03-29T00:00:00Z